Abnormal networks of immune response-related molecules in bone marrow cells from patients with rheumatoid arthritis as revealed by DNA microarray analysis

Table 1 Demographic and rheumatoid arthritis disease characteristics

Patient	RA disease	RF	CRP	steroid	DMARDs
no.	duration (years)	(Unit/mL)	(mg/dL)	(mg/day)
1	21	172	3.3	10	MTX 6 mg/week
2	24	99	2.0	5	Bucillamine 100 mg/day, MTX 4 mg/week
3	40	507	3.3	0	Actarit 200 mg/day
4	45	49	0.3	0
5	9	324	2.6	4
6	16	13	1.4	2.5	Bucillamine 100 mg/day
7	2	242	4.4	7.5	Salazosulfapyridine 1000 mg/day, MTX 6 mg/week
8	24	98	0.9	0	MTX 4 mg/week
9	17	40	2.9	5	MTX 6 mg/week

CRP, C-reactive protein; DMARDs, disease-modifying antirheumatic drugs; MTX, methotrexate;
RA, rheumatoid arthritis; RF, rheumatoid factor.

ISSN: 1478-6362